• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

暴露于冷物理等离子体和等离子体处理过的培养基后,慢性淋巴细胞白血病(CLL)患者白血病细胞中ITGB 3表达增加。

Increased Expression of ITGB 3 in CLL Patient leukemia Cells by Exposure to Cold Physical Plasma and Plasma-treated Medium.

作者信息

Golpour Monireh, Sohbatzadeh Farshad, Alimohammadi Mina, Yazdani Zahra, Fattahi Sadegh, Zaboli Ehsan, Rafiei Alireza, Bekeschus Sander

机构信息

Cancer Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.

Molecular and Cell Biology Research Center (MCBRC), Hemoglobinopathy Institute, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.

出版信息

Int J Mol Cell Med. 2024;13(3):248-258. doi: 10.22088/IJMCM.BUMS.13.3.248.

DOI:10.22088/IJMCM.BUMS.13.3.248
PMID:39493511
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11530951/
Abstract

Chronic lymphocytic leukemia (CLL) is the most prevalent hematological cancer, with various medical interventions. In the recent decade, cold physical plasma has become an interesting agent for future cancer therapy. The goal of this study was to see whether cold physical plasma or cold physical plasma-treated liquid (PTL) affected integrin beta 3 (ITGB3) expression, which is hypothesized to mediate an interaction between cancer stem cells and the bone marrow microenvironment, in CLL patients' blood cells. The metabolic activity, cell death pattern, lipid oxidation and ITGB3 gene expression of these treatments was evaluated. Both direct cold physical plasma and PTL exposure enhanced lipid peroxidation in cells of CLL patients, but to a lesser extent in healthy participants. Furthermore, following 48h of cold physical plasma or PTL exposure, the metabolic activity of leukocytes was preferentially reduced in CLL patient leukocytes. In addition, cold physical plasma and PTL treatment elevated ITGB3 mRNA expression in CLL patients' leukocytes compared to untreated and healthy controls. Collectively, our study suggests selective effects of direct cold physical plasma and PTL exposure on blood leukocytes from leukemia patients, but further and more detailed studies are needed to provide additional rationales for such treatment options as future therapy.

摘要

慢性淋巴细胞白血病(CLL)是最常见的血液系统癌症,有多种医学干预措施。在最近十年中,冷物理等离子体已成为未来癌症治疗中一种引人关注的介质。本研究的目的是观察冷物理等离子体或冷物理等离子体处理液(PTL)是否会影响整合素β3(ITGB3)的表达,据推测该表达介导了癌症干细胞与骨髓微环境之间的相互作用,在CLL患者的血细胞中。对这些处理的代谢活性、细胞死亡模式、脂质氧化和ITGB3基因表达进行了评估。直接冷物理等离子体和PTL暴露均增强了CLL患者细胞中的脂质过氧化,但在健康参与者中程度较轻。此外,在冷物理等离子体或PTL暴露48小时后,CLL患者白细胞中的白细胞代谢活性优先降低。此外,与未处理的和健康对照相比,冷物理等离子体和PTL处理提高了CLL患者白细胞中ITGB3 mRNA的表达。总体而言,我们的研究表明直接冷物理等离子体和PTL暴露对白血病患者血液白细胞有选择性作用,但需要进一步更详细的研究,为将此类治疗方案作为未来治疗提供更多理论依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ad/11530951/55fb1f8015c5/ijmcm-13-248-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ad/11530951/35ad9ac26318/ijmcm-13-248-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ad/11530951/5a155ebc0fe7/ijmcm-13-248-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ad/11530951/a90f5b9dc4dc/ijmcm-13-248-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ad/11530951/55fb1f8015c5/ijmcm-13-248-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ad/11530951/35ad9ac26318/ijmcm-13-248-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ad/11530951/5a155ebc0fe7/ijmcm-13-248-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ad/11530951/a90f5b9dc4dc/ijmcm-13-248-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ad/11530951/55fb1f8015c5/ijmcm-13-248-g004.jpg

相似文献

1
Increased Expression of ITGB 3 in CLL Patient leukemia Cells by Exposure to Cold Physical Plasma and Plasma-treated Medium.暴露于冷物理等离子体和等离子体处理过的培养基后,慢性淋巴细胞白血病(CLL)患者白血病细胞中ITGB 3表达增加。
Int J Mol Cell Med. 2024;13(3):248-258. doi: 10.22088/IJMCM.BUMS.13.3.248.
2
The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro.倍半萜内酯小白菊内酯在体外可诱导B细胞慢性淋巴细胞白血病细胞发生选择性凋亡。
Leukemia. 2006 Jun;20(6):1073-9. doi: 10.1038/sj.leu.2404230.
3
Monoclonal B-cell lymphocytosis in the bone marrow: revisiting the criteria for chronic lymphocytic leukemia/small lymphocytic lymphoma.骨髓中单克隆 B 细胞淋巴增生:重新审视慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的标准。
Hum Pathol. 2022 Jul;125:108-116. doi: 10.1016/j.humpath.2022.04.010. Epub 2022 Apr 25.
4
Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study.SARS-CoV-2 mRNA 疫苗接种在慢性淋巴细胞白血病患者中引发渐进性免疫功能障碍:一项前瞻性队列研究。
PLoS Med. 2023 Jun 29;20(6):e1004157. doi: 10.1371/journal.pmed.1004157. eCollection 2023 Jun.
5
Effective elimination of chronic lymphocytic leukemia cells in the stromal microenvironment by a novel drug combination strategy using redox-mediated mechanisms.通过一种利用氧化还原介导机制的新型药物联合策略有效消除基质微环境中的慢性淋巴细胞白血病细胞。
Mol Med Rep. 2015 Nov;12(5):7374-88. doi: 10.3892/mmr.2015.4364. Epub 2015 Sep 25.
6
SOLUBLE CD150 ISOFORM LEVEL IN PLASMA OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS.慢性淋巴细胞白血病患者血浆中可溶性 CD150 同工型水平。
Exp Oncol. 2024 Feb 3;45(4):457-462. doi: 10.15407/exp-oncology.2023.04.457.
7
Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia.利用新型抗 CXCR4 IgG1 抗体(PF-06747143)靶向慢性淋巴细胞白血病的 CXCR4 途径。
J Hematol Oncol. 2017 May 19;10(1):112. doi: 10.1186/s13045-017-0435-x.
8
A pilot study of high-intensity interval training in older adults with treatment naïve chronic lymphocytic leukemia.一项针对初治慢性淋巴细胞白血病老年患者进行高强度间歇训练的初步研究。
Sci Rep. 2021 Nov 30;11(1):23137. doi: 10.1038/s41598-021-02352-6.
9
Ascorbic acid (vitamin C) synergistically enhances the therapeutic effect of targeted therapy in chronic lymphocytic leukemia.抗坏血酸(维生素 C)协同增强慢性淋巴细胞白血病的靶向治疗疗效。
J Exp Clin Cancer Res. 2020 Oct 28;39(1):228. doi: 10.1186/s13046-020-01738-0.
10
Expanded antigen-experienced CD160CD8effector T cells exhibit impaired effector functions in chronic lymphocytic leukemia.在慢性淋巴细胞白血病中,扩增的抗原经历 CD160CD8effector T 细胞表现出受损的效应功能。
J Immunother Cancer. 2021 Apr;9(4). doi: 10.1136/jitc-2020-002189.

本文引用的文献

1
Current state of NK cell-mediated immunotherapy in chronic lymphocytic leukemia.自然杀伤细胞介导的慢性淋巴细胞白血病免疫治疗的现状
Front Oncol. 2023 Jan 4;12:1077436. doi: 10.3389/fonc.2022.1077436. eCollection 2022.
2
Natural Killer Cells in Chronic Lymphocytic Leukemia: Functional Impairment and Therapeutic Potential.慢性淋巴细胞白血病中的自然杀伤细胞:功能损害与治疗潜力
Cancers (Basel). 2022 Nov 24;14(23):5787. doi: 10.3390/cancers14235787.
3
Cold Physical Plasma in Cancer Therapy: Mechanisms, Signaling, and Immunity.冷等离子体在癌症治疗中的应用:机制、信号转导与免疫。
Oxid Med Cell Longev. 2021 Dec 24;2021:9916796. doi: 10.1155/2021/9916796. eCollection 2021.
4
Cold atmospheric pressure plasma treatment combined with starvation increases autophagy and apoptosis in melanoma in vitro and in vivo.冷等静压等离子体处理联合饥饿在体外和体内增加黑色素瘤的自噬和凋亡。
Exp Dermatol. 2022 Jul;31(7):1016-1028. doi: 10.1111/exd.14544. Epub 2022 Feb 26.
5
Cold Atmospheric Plasma Apoptotic and Oxidative Effects on MCF7 and HCC1806 Human Breast Cancer Cells.冷等离体子对 MCF7 和 HCC1806 人乳腺癌细胞的凋亡和氧化作用。
Int J Mol Sci. 2022 Feb 1;23(3):1698. doi: 10.3390/ijms23031698.
6
Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures.慢性淋巴细胞白血病:诊断与治疗程序的 2022 年更新。
Am J Hematol. 2021 Dec 1;96(12):1679-1705. doi: 10.1002/ajh.26367.
7
Reactive oxygen species: Role in carcinogenesis, cancer cell signaling and tumor progression.活性氧物种:在致癌作用、癌细胞信号转导和肿瘤进展中的作用。
Life Sci. 2021 Nov 1;284:119942. doi: 10.1016/j.lfs.2021.119942. Epub 2021 Sep 10.
8
Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy.活性氧的双重作用及其在癌症治疗中的应用
J Cancer. 2021 Jul 25;12(18):5543-5561. doi: 10.7150/jca.54699. eCollection 2021.
9
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications.自然杀伤细胞在慢性淋巴细胞白血病中的作用及其治疗意义。
Int J Mol Sci. 2021 Jun 22;22(13):6665. doi: 10.3390/ijms22136665.
10
Cold Atmospheric Plasma: A New Strategy Based Primarily on Oxidative Stress for Osteosarcoma Therapy.冷大气等离子体:一种主要基于氧化应激的骨肉瘤治疗新策略。
J Clin Med. 2021 Feb 23;10(4):893. doi: 10.3390/jcm10040893.